e-learning
resources
European Respiratory Review
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The study of risk in pulmonary arterial hypertension
Lewis J. Rubin, Gerald Simonneau, David Badesch, Nazzareno Galiè, Marc Humbert, Anne Keogh, Joseph Massaro, Marco Matucci Cerinic, Olivier Sitbon, Steven Kymes
Source:
Eur Respir Rev 2012 21: 234-238
Journal Issue:
September 2012 - 21 (125)
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lewis J. Rubin, Gerald Simonneau, David Badesch, Nazzareno Galiè, Marc Humbert, Anne Keogh, Joseph Massaro, Marco Matucci Cerinic, Olivier Sitbon, Steven Kymes. The study of risk in pulmonary arterial hypertension. Eur Respir Rev 2012 21: 234-238
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012
A critical analysis of survival in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:218-222
Year: 2012
Predicting survival in pulmonary arterial hypertension in the UK},
Source: Eur Respir J 2012; 40: 604-611
Year: 2012
How to detect disease progression in pulmonary arterial hypertension
Source: Eur Respir Rev 2012; 21: 40-47
Year: 2012
Age, risk and outcomes in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018
Year: 2018
A USA-based registry for pulmonary arterial hypertension: 1982 2006
Source: Eur Respir J 2007; 30: 1103-1110
Year: 2007
An epidemiological study of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: 104-109
Year: 2007
Measurement of quality of life in pulmonary hypertension and its significance
Source: Eur Respir J 2006 Oct 01;28(4):808-815
Year: 2006
Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007
Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
Sildenafil effects on 1-year survival of patients with idiopathic pulmonary arterial hypertension (IPAH)
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era},
Source: Eur Respir J 2012; 40: 881-885
Year: 2012
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017
Year: 2017
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Em
PH
asis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Improving survival in pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 218-220
Year: 2005
Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015
Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept